Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Restructuring Costs (2020 - 2025)

Historic Restructuring Costs for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 6 years, with Q1 2025 value amounting to -$115000.0.

  • Lifecore Biomedical, Inc. \De\'s Restructuring Costs fell 11491.57% to -$115000.0 in Q1 2025 from the same period last year, while for Feb 2025 it was $32.4 million, marking a year-over-year increase of 340161.99%. This contributed to the annual value of -$1.7 million for FY2025, which is 20549.52% down from last year.
  • Lifecore Biomedical, Inc. \De\'s Restructuring Costs amounted to -$115000.0 in Q1 2025, which was down 11491.57% from $31.6 million recorded in Q2 2024.
  • Lifecore Biomedical, Inc. \De\'s Restructuring Costs' 5-year high stood at $31.6 million during Q2 2024, with a 5-year trough of -$115000.0 in Q1 2025.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Restructuring Costs had a median value of $829000.0 in 2022 and averaged $3.3 million.
  • Its Restructuring Costs has fluctuated over the past 5 years, first skyrocketed by 39505000.0% in 2024, then plummeted by 11491.57% in 2025.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Restructuring Costs stood at $627000.0 in 2021, then dropped by 10.21% to $563000.0 in 2022, then plummeted by 72.11% to $157000.0 in 2023, then soared by 20035.03% to $31.6 million in 2024, then plummeted by 100.36% to -$115000.0 in 2025.
  • Its Restructuring Costs stands at -$115000.0 for Q1 2025, versus $31.6 million for Q2 2024 and $771000.0 for Q1 2024.